In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification

LUIS MARTINEZ MARTINEZ2026-01-292026-01-29202310.1016/j.ijantimicag.2023.1069352-s2.0-85169057060https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36844Infectious DiseasesMicrobiology (medical)Pharmacology (medical)In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modificationresearch article